Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: NCT03421379 Eligibility Criteria

Page standards status: Informative

Raw xml | Download


<Group xmlns="http://hl7.org/fhir">
  <id value="267225"/>
  <meta>
    <versionId value="20"/>
    <lastUpdated value="2026-09-02T17:15:21.850Z"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
  <table class="narrative-table">
    <tbody>
<tr>


<th colspan="2" scope="row" class="row-header"><a name="metadata"> </a>Metadata</th>


</tr>

<tr>


<th scope="row" class="row-header">Title</th>



<td class="content-container">NCT03421379 Eligibility Criteria</td>


</tr>













  
<tr>


<th scope="row" class="row-header">Identifier</th>



<td class="content-container">267225</td>


</tr>





























<tr>


<th scope="row" class="row-header">Steward (Publisher)</th>



<td class="content-container">Computable Publishing LLC</td>


</tr>











<tr>


<th scope="row" class="row-header">Description</th>



<td class="content-container"><div><p>Inclusion Criteria:</p>
<ul>
<li>Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)</li>
<li>Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D</li>
<li>Hemoglobin A1c (HbA1c) ≤10%
Exclusion Criteria:</li>
<li>Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month</li>
<li>Have received a total daily dose of insulin &gt;1.2 units per kilogram (U/kg)</li>
</ul>
</div></td>


</tr>



<tr>


<th scope="row" class="row-header">Copyright</th>



<td class="content-container"><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>
</div></td>


</tr>


























































































<tr>
  <th colspan="2" scope="row" class="row-header">Generated using version 0.5.6 of the sample-content-ig Liquid templates</th>
</tr>

    </tbody>
  </table>
</div>
  </text>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name
            value="Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
    <valueMarkdown
                   value="NCT03421379 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267225. Revised 2026-09-02. Available at: https://fevir.net/resources/Group/267225. Computable resource at: https://fevir.net/resources/Group/267225#json."/>
  </extension>
  <url value="https://fevir.net/resources/Group/267225"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="267225"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <type>
      <text value="FEvIR Linking Identifier"/>
    </type>
    <system value="https://fevir.net/FLI"/>
    <value value="NCT03421379 Eligibility Criteria"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="NCT03421379_Eligibility_Criteria"/>
  <title value="NCT03421379 Eligibility Criteria"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="Inclusion Criteria:
* Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)
* Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D
* Hemoglobin A1c (HbA1c) ≤10%
Exclusion Criteria:
* Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month
* Have received a total daily dose of insulin \&gt;1.2 units per kilogram (U/kg)"/>
  <copyright
             value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/>
  <membership value="conceptual"/>
  <combinationMethod value="all-of"/>
  <characteristic>
    <code>
      <text value="Defined by CodeableConcept"/>
    </code>
    <valueCodeableConcept>
      <text
            value="Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Defined by CodeableConcept"/>
    </code>
    <valueCodeableConcept>
      <text
            value="Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Defined by CodeableConcept"/>
    </code>
    <valueCodeableConcept>
      <text value="Hemoglobin A1c (HbA1c) ≤10%"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description value="Hemoglobin A1c (HbA1c) ≤10%"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Defined by CodeableConcept"/>
    </code>
    <valueCodeableConcept>
      <text
            value="Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month"/>
    </valueCodeableConcept>
    <exclude value="true"/>
    <description
                 value="Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Defined by CodeableConcept"/>
    </code>
    <valueCodeableConcept>
      <text
            value="Have received a total daily dose of insulin \&gt;1.2 units per kilogram (U/kg)"/>
    </valueCodeableConcept>
    <exclude value="true"/>
    <description
                 value="Have received a total daily dose of insulin \&gt;1.2 units per kilogram (U/kg)"/>
  </characteristic>
</Group>